Veenat Capsules are prescribed for treatment of Philadelphia chromosome positive CML & ALL. They are formulated having imatinib as active ingredient with chemical formula C29H31N7O and molecular weight of 493.603 g/mol. These capsules work by binding to active site of tyrosine kinases and inhibit their activity. Veenat Capsules have targeted mode of action against bcr-abl, hence do not inhibit other enzymes. Upon consumption, they rapidly get absorbed with 98% bioavailability.
Mainly get metabolized by CYP3A4 in liver
Eliminated in bile & feces
Up to 95% of protein binding ability